DRCMR Logo 300px Color
 
Joakim Ölmestig

Email

Tel.

+45 3868 6553

Position

PhD Student

Affiliations

Herlev Gentofte Hospital, Neurovascular Research Unit

Research Interests

My main area of interest is ischemic stroke, cerebral small vessel disease, and vascular dementia. As a part of my PhD, we will investigate if the medication, tadalafil, improves cerebral blood flow and cognition, in patients with cerebral small vessel disease and stroke

Curriculum Vitae

Education

2018

MSc in Medicine, University of Copenhagen

2013

BSc in Medicine, University of Copenhagen

Employments

2021 - Present

PhD Student, Department of Neurology, Herlev Gentofte Hospital and DRCMR, Hvidovre Hospital

2019 - 2021

Neurology Resident and Research Assistant, Department of Neurology, Herlev Gentofte Hospital

2018 - 2019

Internship, General practice, Næstved

2018 - 2018

Internship, Emergency Department, Slagelse Hospital

2016 - 2017

Research year student/scholarship, Department of Neurology, Herlev Gentofte Hospital

Full CV

Publications

Ölmestig J, Marlet IR, Hansen RH, Rehman S, Krawcyk RS, Rostrup E, Lambertsen KL, Kruuse C. Tadalafil may improve cerebral perfusion in small-vessel occlusion stroke-a pilot study. Brain Commun. 2020 Feb 20;2(1):fcaa020. doi: 10.1093/braincomms/fcaa020. eCollection 2020.

Marlet IR, Ölmestig JNE, Vilsbøll T, Rungby J, Kruuse C. Neuroprotective Mechanisms of Glucagon-like Peptide-1-based Therapies in Ischaemic Stroke: A Systematic Review based on Pre-Clinical Studies. Basic Clin Pharmacol Toxicol. 2018 Jun;122(6):559-569. doi: 10.1111/bcpt.12974. Epub 2018 Mar 15.

Dombernowsky NW, Ölmestig JNE, Witting N, Kruuse C. Role of neuronal nitric oxide synthase (nNOS) in Duchenne and Becker muscular dystrophies - Still a possible treatment modality? Neuromuscul Disord. 2018 Nov;28(11):914-926. doi: 10.1016/j.nmd.2018.09.001. Epub 2018 Sep 11.

Ölmestig JNE, Marlet IR, Hainsworth AH, Kruuse C. Phosphodiesterase 5 inhibition as a therapeutic target for ischemic stroke: A systematic review of preclinical studies. Cell Signal. 2017 Oct;38:39-48. doi: 10.1016/j.cellsig.2017.06.015. Epub 2017 Jun 22.